Search research articles
Contact Us
Filters
Showing results (471-480 of 706) with videos related to
Page
of 71
Sort By:
Journal of the American College of Cardiology
|
January 29, 2008
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study
Olga A Iakoubova, Marc S Sabatine, Charles M Rowland, et al.
JACC. Cardiovascular Imaging
|
February 13, 2009
Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography
Quynh A Truong, Jagmeet P Singh, Christopher P Cannon, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 3, 2016
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin
William B White, Craig A Wilson, George L Bakris, et al.
Journal of the American College of Cardiology
|
February 2, 2008
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction
C Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of the American Heart Association
|
October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Pontus Andell, Stefan K James, Christopher P Cannon, et al.
Journal of the American College of Cardiology
|
February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study
Patricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Clinical Cardiology
|
October 30, 2013
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry
Fátima Rodriguez, Christopher P Cannon, Ph Gabriel Steg, et al.
Clinical Therapeutics
|
April 14, 2025
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence
Mario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, et al.
The American Journal of Cardiology
|
April 14, 2009
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance
Brahmajee K Nallamothu, Harlan M Krumholz, Eric D Peterson, et al.
The American Journal of Cardiology
|
January 12, 2020
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)
Jurrien M Ten Berg, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Page
of 71
Search research articles
Search
Showing results (471-480 of 706) with videos related to
Sort By:
Page
of 71
Journal of the American College of Cardiology
|
January 29, 2008
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study
Olga A Iakoubova, Marc S Sabatine, Charles M Rowland, et al.
JACC. Cardiovascular Imaging
|
February 13, 2009
Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography
Quynh A Truong, Jagmeet P Singh, Christopher P Cannon, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 3, 2016
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin
William B White, Craig A Wilson, George L Bakris, et al.
Journal of the American College of Cardiology
|
February 2, 2008
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction
C Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of the American Heart Association
|
October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Pontus Andell, Stefan K James, Christopher P Cannon, et al.
Journal of the American College of Cardiology
|
February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study
Patricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Clinical Cardiology
|
October 30, 2013
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry
Fátima Rodriguez, Christopher P Cannon, Ph Gabriel Steg, et al.
Clinical Therapeutics
|
April 14, 2025
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence
Mario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, et al.
The American Journal of Cardiology
|
April 14, 2009
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance
Brahmajee K Nallamothu, Harlan M Krumholz, Eric D Peterson, et al.
The American Journal of Cardiology
|
January 12, 2020
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)
Jurrien M Ten Berg, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Page
of 71